CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia

• Autori principali: Kamonporn Kotemul (Autore), Watchara Kasinrerk (Autore), Nuchjira Takheaw (Autore)
• Natura: Libro
• Pubblicazione: Open Exploration Publishing Inc., 2024-02-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Monoclonal antibodies (mAbs) are an effective drug for targeted immunotherapy in several cancer types. However, so far, no antibody has been successfully developed for certain types of cancer, including T-cell acute lymphoblastic leukemia (T-ALL). T-ALL is an aggressive hematologic malignancy. T-ALL...